The Risk of Alcohol Dependence is Increased After Gastric Bypass Surgery (Abstract #266)
Bariatric patients have significantly higher rates of inpatient treatment for psychiatric disease before and after surgery compared to the general population and post-operatively, gastric bypass is associated with a two-fold
increased risk of inpatient treatment for alcohol abuse compared to restrictive surgery. Patients were assessed in terms of inpatient treatment for psychosis, depression, attempted suicide, substance abuse and alcoholism. The increased risk of hospitalization remained after surgery for all disorders except psychosis.
Dr. stlund will present these data on Saturday, May 7 at 4:00 p.m. in S503, McCormick Place.
One year results of an endoscopic, duodenal-jejunal exclusion device for weight loss and control of type 2 diabetes (EndoBarrier) (Abstract #792)
Investigators have performed extensive research on the success of a novel weight loss device that functions almost exactly like gastric bypass surgery but without the painful and permanent effects of surgery. The duodenal-jejunal bypass liner, or EndoBarrier, is an endoscopic implant that mimics the intestinal bypass component of the common Roux-en-Y gastric bypass procedure. Use of this nonsurgical, reversible implant in obese patients with type 2 diabetes resulted in improved blood sugar control, significant weight loss and reductions in LDL and triglyceride levels, important cardiovascular risk factors.
Bruno da Costa Martins, MD, Attending Physician in Endoscopy Department of Hospital das Clinicas, Sao Paulo, Brazil, will present these data on Monday, May 9 at 2:15 p.m. in S104, McCormick Place.
|Contact: Amy Levey|
Digestive Disease Week